Commercially Insured/Eligible Uninsured Patients and Medicare Part D Insured Patients


Each of these programs has different terms, with a minimum co-pay and a maximum benefit.


Commercially Insured/Eligible Uninsured Patients

Eligible patients can receive payment assistance, limiting their prescription co-pay cost.


Instant Savings Offer

Pay NO MORE THAN $35*. Most eligible commercially insured patients pay no more than $35 co-pay for 1st prescription and eligible refills. Exclusively at Walgreens and other participating independent pharmacies. 

Discounted pricing is also available for eligible uninsured patients.*



If you have any questions regarding your eligibility or benefits, please call
1-855-280-0580.

*This offer is only valid for patients with commercial insurance and eligible uninsured patients.This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. This offer is good only in the U.S. at retail pharmacies owned and operated by Walgreen Co. (or its affiliates) or other participating independent retail pharmacies. This offer is not valid in Massachusetts or Minnesota or where otherwise prohibited, taxed or otherwise restricted.
Click here for all eligibility criteria and terms and conditions that apply.

Medicare Part D Insured Patients

Patients may opt-in to the program to pay no more than $60. For more information, click here.





INDICATION FOR PROLENSA (bromfenac ophthalmic solution) 0.07%

PROLENSA (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in patients after cataract surgery.

IMPORTANT SAFETY INFORMATION ABOUT PROLENSA
  • PROLENSA contains sodium sulfite, a substance that may cause allergic reactions, some severe, in certain people. In addition, tell your doctor if you have had an allergic reaction to any other medications.

  • Slow or delayed healing may occur while using non-steroidal anti-inflammatory drugs (NSAIDs) such as PROLENSA.

  • Use of NSAIDs in the eye may result in certain serious eye conditions that can be sight threatening. Tell your doctor immediately about any side effect that you may have.

  • Replace bottle cap after using and do not touch dropper tip to any surface in order to avoid contamination of the bottle.

  • Remove contact lenses prior to using PROLENSA. The preservative in PROLENSA, benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may be reinserted after 10 minutes following administration of PROLENSA.

  • If more than one eye medicine is being used, use the eye medicines at least 5 minutes apart.

  • The most common side effects (seen in 3%-8% of patients) were inflammation of the eye, foreign body sensation, eye pain, light sensitivity, and blurred vision.


Please click here for Prescribing Information about PROLENSA.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.


PRA.0025.USA.16